Tomoaki Wada

787 citations
35 papers · 610 indexed · h-index 15
Topics
Acute Myeloid Leukemia Research (5 papers)Epilepsy research and treatment (4 papers)Genomics and Chromatin Dynamics (3 papers)

In The Last Decade

Tomoaki Wada

32 papers receiving 594 citations

Peers

Tomoaki Wada
Comparison fields: 5 of 74
  • Molecular Biology 310
  • Oncology 179
  • Pathology and Forensic Medicine 141
  • Hematology 87
  • Cancer Research 75
Replace Phillip Koeffler with:
Phillip Koeffler United States
Shiro Fujii Japan
Milena Ivanova Bulgaria
John J. Kanalas United States
Siew Meng Chong Singapore
Roberto Caporale Italy
Anne-Sophie Govaerts Belgium
Elisabeth Ludwig Germany
Flavia Bottarel Italy
Cheng‐Chin Wu Taiwan
Tomoaki Wada relative to Phillip Koeffler United States Phillip Koeffler's profile →
Citations per field
00.5×1.5×
Phillip Koeffler · 1×
Citations per year

Countries citing papers authored by Tomoaki Wada

Since Specialization
Citations

This map shows the geographic impact of Tomoaki Wada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomoaki Wada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomoaki Wada more than expected).

Fields of papers citing papers by Tomoaki Wada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomoaki Wada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomoaki Wada. The network helps show where Tomoaki Wada may publish in the future.

Co-authorship network of co-authors of Tomoaki Wada

This figure shows the co-authorship network connecting the top 25 collaborators of Tomoaki Wada. A scholar is included among the top collaborators of Tomoaki Wada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomoaki Wada. Tomoaki Wada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 8
2 6
3 28
4 10
5 18
6 82
7 9
8 16
9 21
10 47
11 19
12 43
13 23
14 105
15 23
16 4
17 3
18 11
19 1
20 17

About Tomoaki Wada

Tomoaki Wada is a scholar working on Internal Medicine, Hematology and Pathology and Forensic Medicine, having authored 35 papers that have together received 610 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (5 papers), Epilepsy research and treatment (4 papers) and Genomics and Chromatin Dynamics (3 papers). The work is most often cited by research in Pathology and Forensic Medicine (141 citations), Hematology (87 citations) and Oncology (179 citations). Tomoaki Wada has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Hiroyuki Mano, Koji Koinuma, Young Lim Choi, Yoshihiro Yamashita, Jun Ota, Ruri Ohki, Hideo Nagai, Shuji Takada, Ruri Kaneda and Yasuyuki Miyakura. Their work appears in journals such as Circulation Research, Oncogene and Biochemical and Biophysical Research Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026